Spreadsheet: 6ad3ed86-7f53-4da9-9bf6-d0f44eaa4d11
Sheet: Sheet1

Table S5:  [NAME] list of GO biological process categories for which expression programs | Unnamed: 1 | Unnamed: 2 | Unnamed: 3 | Unnamed: 4 | Unnamed: 5 | Unnamed: 6 | Unnamed: 7 | Unnamed: 8 | Unnamed: 9 | Unnamed: 10 | Unnamed: 11 | Unnamed: 12
discovered in the infection time-series data were significantly enriched.
EP# | GO categories
1 | none
2 | protein amino acid dephosphorylation GO:0006470, p=0.001177249345385989 (10\231) | hemostasis GO:0007599, p=0.002039857169121251 (9\231) | central nervous system development GO:0007417, p=0.002870608725253243 (7\231)
3 | positive regulation of cell proliferation GO:0008284, p=0.0020449588382818185 (12\166)
4 | inflammatory response GO:0006954, p=1.0173134683655327E-4 (12\141) | protein amino acid dephosphorylation GO:0006470, p=0.0031714559899966854 (7\141)
5 | respiratory gaseous exchange GO:0007585, p=0.002274916488623324 (6\382)
6 | none
7 | none
8 | none
9 | none
10 | positive regulation of I-kappaB kinase/NF-kappaB cascade GO:0043123, p=5.73484312709982E-4 (6\132) | positive regulation of signal transduction GO:0009967, p=6.965525928638305E-4 (7\132) | regulation of I-kappaB kinase/NF-kappaB cascade GO:0043122, [NAME] (8\132) | cell-matrix adhesion GO:0007160, [NAME] (5\132)
11 | none
12 | none
13 | cell cycle GO:0007049, p=0.0023083596792209393 (20\291)
14 | none
15 | response to virus GO:0009615, p=9.055739524554962E-5 (7\127)
16 | none
17 | none
18 | inflammatory response GO:0006954, p=1.4428988226344863E-5 (12\116) | negative regulation of transcription from RNA polymerase II promoter GO:0000122, p=6.523427774358659E-4 (7\116)
19 | none
20 | cell cycle GO:0007049, p=0.0018077193188811291 (11\114) | cell cycle arrest GO:0007050, p=0.002019334056078015 (5\114)
21 | none
22 | negative regulation of cell proliferation GO:0008285, p=0.0015981058552430039 (15\258)
23 | none
24 | none
25 | cell cycle GO:0007049, p=6.323071750977682E-4 (20\262) | negative regulation of transcription from RNA polymerase II promoter GO:0000122, p=0.0016939388406416178 (10\262)
26 | none
27 | none
28 | [NAME] receptor [NAME] signaling pathway GO:0007169, p=0.002188835771140152 (10\119)
29 | none
30 | none
31 | none
32 | mitosis GO:0007067, p=1.9438830875995183E-4 (6\111) | MAPKKK cascade GO:0000165, p=6.329214786084947E-4 (5\111) | T cell activation GO:0042110, p=0.002841292194093681 (6\111)
33 | anti-apoptosis GO:0006916, p=7.650779578982636E-5 (13\190)
34 | none
35 | cell cycle GO:0007049, p=0.0021459582587410875 (13\152)
36 | circulation GO:0008015, p=0.0021858496491630186 (6\180)
37 | none
38 | JAK-STAT cascade GO:0007259, p=3.502864187121535E-5 (5\161) | antimicrobial humoral response (sensu Vertebrata) GO:0019735, p=2.9869115355474207E-4 (8\161) | cytokine and chemokine mediated signaling pathway GO:0019221, [NAME] (5\161) | humoral defense mechanism (sensu Vertebrata) GO:0016064, p=0.0010709642662233287 (8\161) | positive regulation of cell proliferation GO:0008284, [NAME] (12\161) | chemotaxis GO:0006935, p=0.002110118209476042 (10\161)
39 | none
40 | none
41 | inflammatory response GO:0006954, p=0.0012423304561636206 (12\185)
42 | regulation of adenylate cyclase activity GO:0045761, p=1.5363948926727655E-4 (7\227) | activation of MAPK activity GO:0000187, p=3.8903579704874236E-4 (7\227) | positive regulation of cyclase activity GO:0031281, p=7.507266005192248E-4 (5\227) | adenylate cyclase activation GO:0007190, p=7.507266005192248E-4 (5\227) | positive regulation of adenylate cyclase activity GO:0045762, p=7.507266005192248E-4 (5\227) | positive regulation of MAPK activity GO:0043406, p=0.002600566051157216 (7\227)
43 | none
44 | Golgi vesicle transport GO:0048193, p=0.0023665895477485988 (8\319)
45 | none
46 | none
47 | none
48 | none
49 | none
50 | membrane fusion GO:0006944, p=0.002172936819815785 (5\217)
51 | none
52 | none
53 | none
54 | none
55 | neuropeptide signaling pathway GO:0007218, p=0.0020918833046619234 (5\173)
56 | DNA replication initiation GO:0006270, p=6.477721124598101E-5 (5\201)
57 | muscle development GO:0007517, p=2.904782576795828E-4 (9\134)
58 | angiogenesis GO:0001525, p=0.0030238572604767144 (5\125)
59 | none
60 | none
61 | none
62 | none
63 | none
64 | none
65 | none
66 | none
67 | none
68 | rRNA metabolism GO:0016072, p=8.381567326354311E-4 (7\312) | rRNA processing GO:0006364, p=8.381567326354311E-4 (7\312) | regulation of translational initiation GO:0006446, p=0.002323102518711817 (5\312) | glycogen metabolism GO:0005977, p=0.002370097628403789 (6\312) | nuclear mRNA splicing, via spliceosome GO:0000398, p=0.002569862467146189 (9\312) | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile GO:0000377, p=0.002569862467146189 (9\312)
69 | cell fate commitment GO:0045165, p=2.1934715851990028E-4 (5\154)
70 | tricarboxylic acid cycle GO:0006099, p=1.6676080341060384E-6 (8\335) | acetyl-CoA catabolism GO:0046356, p=1.6676080341060384E-6 (8\335) | acetyl-CoA metabolism GO:0006084, [NAME] (9\335) | coenzyme catabolism GO:0009109, p=6.183960837328195E-4 (8\335) | nuclear mRNA splicing, via spliceosome GO:0000398, p=0.001104818935929397 (10\335) | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile GO:0000377, p=0.001104818935929397 (10\335)
71 | protein targeting to membrane GO:0006612, p=0.001060712724122559 (5\262)
72 | none
73 | nervous system development GO:0007399, p=0.001468120956375607 (12\175)
74 | chloride transport GO:0006821, p=2.892268359669936E-4 (5\112) | positive regulation of signal transduction GO:0009967, p=0.0016342722618724048 (6\112)
75 | none
76 | cell cycle GO:0007049, p=0.0010232022080611802 (15\176)
77 | antigen processing, exogenous antigen via MHC class II GO:0019886, p=4.5872212806052914E-8 (6\111) | antigen presentation, exogenous antigen GO:0019884, p=1.2414553436157494E-4 (5\111) | antigen processing GO:0030333, p=2.959778682308789E-4 (6\111) | chemotaxis GO:0006935, p=5.385657292190649E-4 (9\111) | inflammatory response GO:0006954, p=0.0011039144311747462 (9\111)
78 | excretion GO:0007588, p=0.0018435062504796873 (6\179)
79 | none
80 | none
81 | inflammatory response GO:0006954, p=0.0029262699512885293 (13\232)
82 | nucleotide-excision repair GO:0006289, p=5.885153433949908E-4 (6\239) | energy coupled proton transport, down electrochemical gradient GO:0015985, p=0.0016487040690162935 (5\239) | ATP synthesis coupled proton transport GO:0015986, p=0.0016487040690162935 (5\239)
83 | none
84 | none
85 | DNA replication GO:0006260, p=4.349666604649416E-4 (13\290)
86 | tRNA aminoacylation for protein translation GO:0006418, p=0.0011309642928578612 (7\171) | tRNA aminoacylation GO:0043039, p=0.0011309642928578612 (7\171)
87 | negative regulation of cell proliferation GO:0008285, p=0.0021539974215305513 (10\139)
88 | none
89 | neuron migration GO:0001764, p=7.072437406498988E-4 (5\154)
90 | tricarboxylic acid cycle GO:0006099, p=1.5892981223064595E-5 (6\203) | acetyl-CoA catabolism GO:0046356, p=1.5892981223064595E-5 (6\203) | energy coupled proton transport, down electrochemical gradient GO:0015985, p=7.507811935858477E-5 (6\203) | ATP synthesis coupled proton transport GO:0015986, p=7.507811935858477E-5 (6\203) | nucleoside phosphate metabolism GO:0006753, p=2.4350533853756406E-4 (6\203) | ATP biosynthesis GO:0006754, p=2.4350533853756406E-4 (6\203) | acetyl-CoA metabolism GO:0006084, p=7.658795114925399E-4 (6\203) | purine ribonucleoside triphosphate biosynthesis GO:0009206, p=9.332589614033937E-4 (6\203) | purine nucleoside triphosphate biosynthesis GO:0009145, p=9.332589614033937E-4 (6\203) | coenzyme catabolism GO:0009109, p=0.0011274420597924273 (6\203)
91 | nuclear mRNA splicing, via spliceosome GO:0000398, p=5.862719405080874E-5 (12\337) | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile GO:0000377, p=5.862719405080874E-5 (12\337) | energy coupled proton transport, down electrochemical gradient GO:0015985, p=1.5347447490665633E-4 (7\337) | ATP synthesis coupled proton transport GO:0015986, p=1.5347447490665633E-4 (7\337) | purine nucleoside triphosphate biosynthesis GO:0009145, p=5.010579791819847E-4 (8\337) | purine ribonucleoside triphosphate biosynthesis GO:0009206, p=5.010579791819847E-4 (8\337) | nucleoside phosphate metabolism GO:0006753, p=5.891846938794743E-4 (7\337) | ATP biosynthesis GO:0006754, p=5.891846938794743E-4 (7\337) | positive regulation of I-kappaB kinase/NF-kappaB cascade GO:0043123, p=0.001139453012440561 (9\337) | purine ribonucleotide biosynthesis GO:0009152, p=0.0013745458210053796 (9\337) | ribonucleoside triphosphate biosynthesis GO:0009201, p=0.0027961090647082854 (8\337)
92 | antigen processing, exogenous antigen via MHC class II GO:0019886, p=1.1160097037632433E-4 (5\250) | antigen presentation, exogenous antigen GO:0019884, [NAME] (6\250) | glycolysis GO:0006096, p=0.0010400134027340746 (7\250) | glucose catabolism GO:0006007, [NAME] (7\250)
93 | nuclear mRNA splicing, via spliceosome GO:0000398, p=3.0354238226504293E-5 (9\172) | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile GO:0000377, p=3.0354238226504293E-5 (9\172) | cell cycle arrest GO:0007050, p=3.7417263653749533E-4 (7\172) | negative regulation of protein kinase activity GO:0006469, p=0.0028362068055630685 (5\172)
94 | none
95 | none
96 | tricarboxylic acid cycle GO:0006099, p=5.594325782694032E-4 (5\245) | acetyl-CoA catabolism GO:0046356, p=5.594325782694032E-4 (5\245)
97 | inflammatory response GO:0006954, p=1.3073805005259231E-7 (19\199) | chemotaxis GO:0006935, p=1.6728540970345485E-5 (15\199) | apoptosis GO:0006915, p=2.675834741872052E-5 (17\199) | positive regulation of cell proliferation GO:0008284, [NAME] (17\199) | positive regulation of lymphocyte proliferation GO:0050671, p=1.6692476078816743E-4 (6\199) | antimicrobial humoral response (sensu Vertebrata) GO:0019735, p=2.4585874562033094E-4 (9\199) | negative regulation of cell proliferation GO:0008285, p=3.5287729647526245E-4 (14\199) | regulation of cyclin dependent protein kinase activity [NAME], p=3.5825725136240383E-4 (6\199) | protein amino acid dephosphorylation GO:0006470, p=3.6531778466830644E-4 (10\199) | positive regulation of T cell proliferation GO:0042102, p=5.483805006659681E-4 (5\199) | humoral defense mechanism (sensu Vertebrata) GO:0016064, p=0.0010093450916031088 (9\199) | regulation of T cell proliferation GO:0042129, p=0.0010493655029635285 (7\199)
98 | nuclear mRNA splicing, via spliceosome GO:0000398, p=9.116895249062784E-4 (8\215) | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile GO:0000377, p=9.116895249062784E-4 (8\215)
99 | inflammatory response GO:0006954, p=3.5551561694546763E-12 (24\191) | humoral defense mechanism (sensu Vertebrata) GO:0016064, p=1.041261161738305E-7 (14\191) | chemotaxis GO:0006935, p=4.1442987142037424E-7 (17\191) | antimicrobial humoral response (sensu Vertebrata) GO:0019735, p=6.138280910228389E-7 (12\191) | anti-apoptosis GO:0006916, p=8.076793571665242E-5 (13\191) | response to virus GO:0009615, p=1.8779185935191567E-4 (8\191) | apoptosis GO:0006915, p=7.034858254681975E-4 (14\191) | antimicrobial humoral response GO:0019730, p=8.756653909137713E-4 (12\191)
100 | none
101 | purine ribonucleotide biosynthesis GO:0009152, p=3.5153732910186974E-6 (10\201) | purine ribonucleoside triphosphate biosynthesis GO:0009206, p=1.1674006074235965E-4 (7\201) | purine nucleoside triphosphate biosynthesis GO:0009145, p=1.1674006074235965E-4 (7\201) | ribonucleoside triphosphate biosynthesis GO:0009201, p=5.846906006038433E-4 (7\201) | energy coupled proton transport, down electrochemical gradient GO:0015985, p=7.539360799458938E-4 (5\201) | ATP synthesis coupled proton transport GO:0015986, p=7.539360799458938E-4 (5\201) | purine nucleotide biosynthesis GO:0006164, p=9.085647140445463E-4 (11\201) | protein import GO:0017038, p=0.0015273101560348001 (6\201) | nucleoside phosphate metabolism GO:0006753, p=0.0019118473869385033 (5\201) | ATP biosynthesis GO:0006754, p=0.0019118473869385033 (5\201)
102 | response to virus GO:0009615, p=1.3035931924254562E-5 (10\221) | positive regulation of signal transduction GO:0009967, p=3.179015676713082E-5 (11\221) | positive regulation of I-kappaB kinase/NF-kappaB cascade GO:0043123, p=4.7426747055490104E-5 (9\221) | positive regulation of T cell proliferation GO:0042102, p=8.864314925807193E-4 (5\221) | regulation of T cell proliferation GO:0042129, p=0.0019324047118943755 (7\221) | induction of apoptosis GO:0006917, p=0.002067485224748866 (15\221) | positive regulation of lymphocyte proliferation GO:0050671, p=0.0023551726791820604 (5\221)
103 | inflammatory response GO:0006954, p=2.366876756743075E-5 (13\142) | humoral defense mechanism (sensu Vertebrata) GO:0016064, p=0.002340917243827456 (7\142) | chemotaxis GO:0006935, p=0.0030770621950948485 (9\142)
104 | [NAME] development GO:0048535, p=4.1088150437573745E-8 (6\109) | antimicrobial humoral response (sensu Vertebrata) GO:0019735, p=1.5273646624913706E-4 (7\109) | anti-apoptosis GO:0006916, p=2.6107415166010117E-4 (9\109) | humoral defense mechanism (sensu Vertebrata) GO:0016064, p=4.9246548148274E-4 (7\109) | angiogenesis GO:0001525, p=0.0016550146875811134 (5\109) | axon guidance GO:0007411, p=0.0016550146875811134 (5\109) | T cell activation GO:0042110, p=0.0025924491019777562 (6\109) | positive regulation of cell proliferation GO:0008284, [NAME] (9\109)